Evidence map›Paper›PMID 33420913›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

Reversible widespread brain

E Mairal, B Barberon, N Laine, M Coulange, Eric Guedj

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

E MairalDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, 54000, Nancy, France.
B BarberonAPHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
N LaineAPHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
M CoulangeAPHM, INSERM 1263 - INRA 1260, TEAM V: Adenosinergic System and Cardiovascular Disease, Sainte-Marguerite Hospital, Marseille, Pôle RUSH, Hyperbaric Medicine Centre, Aix Marseille University, Marseille, France.
Eric GuedjAix Marseille Univ, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Marseille, France. eric.guedj@ap-hm.fr.ORCID http://orcid.org/0000-0003-1912-6132
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fatigue Syndrome, ChronicHyperbaric OxygenationBrainFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID33420913
OpenAlexW3120578228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.